Crystal Tsui from Portal is at #FOCIS2024! Talk to her about our latest #immune cell engineering data with gene editing and RNA applications. Clinical workflows, point-of-care solutions and, of course, cell Pokemon cards are also great topics! https://lnkd.in/ecP-sDUu
Portal’s Post
More Relevant Posts
-
⭐ ⭐ ⭐ ⭐ ⭐ You can see what previous attendees thought about our short online course An Introduction to Cell & Gene Therapies: A Beginner's Guide which is due to run again this June 27. #educolifesciences #cellandgenetherapy #cgt
To view or add a comment, sign in
-
Have you had a chance to explore our recent whitepapers? Would you like to revisit the ones that caught your attention? Over the last four weeks, we published four whitepapers looking at a different aspect of how #DecentralizedManufacturing of cell and gene therapies can be achieved and used to increase accessibility for rural and global communities. You can read the entire series here: www.realm.bio/insights A BIG thank you to everyone who collaborated with us and helped to create this series! Domhnall Mc Gowan, Erika Francoeur, Craig Hasilo, Jenny Ligon, Stephen Stewart, and Enayat Mohammad, PMP
To view or add a comment, sign in
-
Process Development to Commercial Manufacturing, CMC, GMP, Biopharma, Cell and Gene Therapy, Facility Design and Start-up, CDMO selection and management, Quality Systems
#CMC #techtransfer #cellandgenetherapy #manufacturing Advancing Manufacture of Cell and Gene Therapies VIII is only a week away. I am looking forward to the conference and meeting old and new colleagues and friends. Special Thanks to my Poster Co-author Nollaig Buckley
To view or add a comment, sign in
-
Exa-cel findings are finally published in NEJM Group as phase III data from CLIMB SCD-121, led by Haydar Frangoul, verified the efficacy of the gene editing therapy for patients with SCD. Read more and check out our interview with Dr. Frangoul: https://lnkd.in/eaDcbCTU
To view or add a comment, sign in
-
Assess genomic integrity & off-target events with OGM! Check out our new cell & gene therapy webpage with a ton of new resources! Cell&Gene Webpage: https://lnkd.in/gY3ejXNS Flipbook: https://lnkd.in/g-sT_f3P #OpticalGenomeMapping #CellGeneTherapy #GenomicIntegrity
To view or add a comment, sign in
-
Industry, academia, healthcare systems and academia are all echoing the growing demand of skilled workforce to enable their cell and gene therapy journey at #ISCT2024. Check out the various training initiatives offered by ISCT: https://buff.ly/3KHpHCt
To view or add a comment, sign in
-
Attn: Benefits folks! The number of FDA approved cell & gene therapies is expected to more than quadruple by 2032 (85 new gene therapies across more than 12 therapeutic areas). What info do you need to best inform your future benefit decisions? Share your perspectives in Integrated Benefits Institute's 5-minute study below 👇
Calling all employee benefit leaders and consultants, the Integrated Benefits Institute (IBI) would like to understand your perspectives on cell and gene therapies and information interests related to clinical innovation and costs. Your feedback is critical and the survey will take less than five minutes! https://lnkd.in/e4fS3eP7 The survey is for all individuals no matter their depth of cell and gene therapy knowledge or experience. Aggregate study findings will be shared broadly and help inform the development of future materials. #humanresources #employeewellbeing #celltherapy #genetherapy
To view or add a comment, sign in
-
How can we scale up cell and gene therapies to make them accessible to a broader population? Our Head of Cell and Gene, Stuart Lowe has sized up the hurdles in a #ChatsWithChauhrey episode with Rizwan Chaudhrey. Stuart also discusses how automation may be the answer to create more cost-effective manufacturing solutions. Connect with Stuart Lowe and Sebastian Rammensee at #advancedtherapiesweek on the 16th – 19th of January 2024 to continue the conversation. Phacilitate #advancedtherapies #ATW24 #CGT
To view or add a comment, sign in
-
Scrip asks...what does 2024 hold for Biopharma? Part 4: Transformative Technology. AI was the dominant theme – but gene editing, cell therapies and new targeting modalities were also among the highlights. More exclusive insight from industry titans you won't find elsewhere... #AI #geneediting #celltherapies
To view or add a comment, sign in
-
Explore the common misconceptions and key considerations for selecting critical raw materials used in the production of cell and gene therapies in this upcoming webinar, sponsored by Sartorius >>> https://hubs.ly/Q02QM9Vd0
To view or add a comment, sign in
2,645 followers